JPL Wealth Management »

Actuate Therapeutics shares owned by JPL Wealth Management

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by JPL Wealth Management from 13F filings

Historical chart of JPL Wealth Management investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by JPL Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by JPL Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2 1 2.00

More positions owned by JPL Wealth Management

Spdr Series Trust St Str P500etf (SPYM)
UnitedHealth (UNH)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Broadcom (AVGO)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Ea Series Trust Alpha Architect (CAOS)
Caterpillar (CAT)
Ea Series Trust Alpha Architect (AAEQ)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Vanguard Index Fds Total Stk Mkt (VTI)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ea Series Trust Us Quan Momentum (QMOM)
Ishares Tr Ishares Semicdtr (SOXX)

View all positions for JPL Wealth Management

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Capital Management
AQR Capital Management
Geode Capital Management
Texas Capital Bank Wealth Management Services
Palogic Value Management
Millennium Management
BlackRock
ABS Direct Equity Fund
ABS Investment Management
State Street Corporation
Vanguard Fiduciary Trust
Rock Creek Group
Jane Street

View all funds holding Actuate Therapeutics